Published in Health and Medicine Week, September 1st, 2003
Scientists in France "have developed a preimplantation genetic diagnosis (PGD) strategy for Duchenne muscular dystrophy (DMD) allowing the simultaneous amplification of four exons (6, 8, 28 and 32) of the dystrophin gene together with ZFX/ZFY genes for gender determination."
"Preliminary experiments were carried out on 215 single lymphocytes from male and female individuals," according to A. Girardet and coauthors at the University of Montpellier Hospital Center.
"Amplification rates ranged from 90.2% for exon 6 to 96.7% for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week